Grassi Investment Management’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$301K Sell
2,379
-50
-2% -$6.14K 0.02% 112
2025
Q1
$311K Sell
2,429
-2,830
-54% -$384K 0.03% 107
2024
Q4
$695K Sell
5,259
-1,000
-16% -$141K 0.06% 85
2024
Q3
$911K Sell
6,259
-450
-7% -$65.1K 0.08% 79
2024
Q2
$921K Sell
6,709
-4,450
-40% -$594K 0.08% 75
2024
Q1
$1.53M Buy
11,159
+359
+3% +$49K 0.14% 63
2023
Q4
$1.47M Sell
10,800
-125
-1% -$15.3K 0.15% 63
2023
Q3
$1.34M Sell
10,925
-950
-8% -$121K 0.15% 68
2023
Q2
$1.51M Sell
11,875
-100
-0.8% -$13K 0.17% 68
2023
Q1
$1.55M Sell
11,975
-35
-0.3% -$4.58K 0.19% 69
2022
Q4
$1.58M Sell
12,010
-2,300
-16% -$297K 0.21% 70
2022
Q3
$1.67M Sell
14,310
-375
-3% -$46.6K 0.24% 71
2022
Q2
$1.73M Sell
14,685
-1,205
-8% -$143K 0.23% 73
2022
Q1
$2.07M Buy
15,890
+400
+3% +$52.1K 0.22% 73
2021
Q4
$2.36M Buy
15,490
+475
+3% +$73.5K 0.24% 74
2021
Q3
$2.43M Buy
15,015
+110
+0.7% +$18.5K 0.27% 68
2021
Q2
$2.44M Buy
14,905
+125
+0.8% +$19.3K 0.26% 67
2021
Q1
$2.23M Buy
14,780
+175
+1% +$27.8K 0.25% 67
2020
Q4
$2.21M Buy
14,605
+1,925
+15% +$275K 0.28% 68
2020
Q3
$1.72M Buy
+12,680
New +$1.72M 0.24% 67

Other funds holding IBB

Grassi Investment Management's IBB Position: Q2 2025 in Review

Grassi Investment Management reduced its iShares Biotechnology ETF (IBB) stake by 2.1% in Q2 2025, selling an estimated $6.14K and leaving 2,379 shares worth $301K. The position accounts for 0.02% of the portfolio, ranked #112.

Grassi Investment Management first reported a position in IBB in Q3 2020 and has held it in 20 quarters since. The position peaked at $2.44M in Q2 2021. 797 funds tracked by Wall St. Rank hold IBB as of Q2 2025.

  • Grassi Investment Management held 2,379 shares of iShares Biotechnology ETF worth $301K as of Q2 2025.
  • Grassi Investment Management sold 50 iShares Biotechnology ETF shares in Q2 2025, an estimated $6.14K.
  • iShares Biotechnology ETF made up 0.02% of Grassi Investment Management's portfolio in Q2 2025, its #112 holding.
  • Grassi Investment Management first reported a position in iShares Biotechnology ETF in Q3 2020 and has held it in 20 quarters since.
  • Grassi Investment Management's iShares Biotechnology ETF position peaked at $2.44M in Q2 2021.
  • 797 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2025.

Based on Grassi Investment Management's 13F filing for Q2 2025, filed 21 Jul 2025.